clonazepam 1 mg
INDICATIONS AND USAGE Seizure Disorders: Clonazepam tablets are useful alone or as an adjunct in the treatment of the Lennox- Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures. In patients with absence seizures (petit mal) who have failed to respond to succinimides, clonazepam tablets may be useful. Some loss of effect may occur during the course of clonazepam treatment (see PRECAUTIONS: Loss of Effect ). Panic Disorder: Clonazepam tablets are indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM-V. Panic disorder is characterized by the occurrence of unexpected panic attacks and associated concern about having additional attacks, worry about the implications or consequences of the attacks, and/or a significant change in behavior related to the attacks. The efficacy of clonazepam tablets was established in two 6- to 9-week trials in panic disorder patients whose diagnoses corresponded to the DSM-lIlR category of panic disorder (see CLINICAL PHARMACOLOGY: Clinical Trials ). Panic disorder (DSM-V) is characterized by recurrent unexpected panic attacks, i.e., a discrete period of intense fear or discomfort in which four (or more) of the following symptoms develop abruptly and reach a peak within 10 minutes: (1) palpitations, pounding heart or accelerated heart rate; (2) sweating; (3) trembling or shaking; (4) sensations of shortness of breath or smothering; (5) feeling of choking; (6) chest pain or discomfort; (7) nausea or abdominal distress; (8) feeling dizzy, unsteady, lightheaded or faint; (9) derealization (feelings of unreality) or depersonalization (being detached from oneself); (10) fear of losing control; (11) fear of dying; (12) paresthesias (numbness or tingling sensations); (13) chills or hot flushes. The effectiveness of clonazepam tablets in long-term use, that is, for more than 9 weeks, has not been systematically studied in controlled clinical trials. The physician who elects to use clonazepam tablets for extended periods should periodically reevaluate the long- term usefulness of the drug for the individual patient (see DOSAGE AND ADMINISTRATION ).
advagen pharma ltd
Related Pills
clonazepam 0.5 mg
advagen pharma ltd
clonazepam 0.5 mg
advagen pharma ltd
clonazepam 1 mg
advagen pharma ltd
buspirone hydrochloride 30 MG Oral Tablet
Amneal Pharmaceuticals NY LLC
buspirone hydrochloride 30 MG Oral Tablet
Amneal Pharmaceuticals NY LLC
buspirone hydrochloride 30 MG Oral Tablet
Amneal Pharmaceuticals NY LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
CLONAZEPAM Tablets USP, 0.5 mg are mottled orange, round, flat-faced, beveled edge tablet, debossed with Λ on one side and scored on the other side. They are supplied as follows: 66 NDC 72888-152-30, bottles of 30. NDC 72888-152-01, bottles of 100. NDC 72888-152-05, bottles of 500. NDC 72888-152-00, bottles of 1000.
CLONAZEPAM Tablets USP, 1 mg are mottled blue, round, flat-faced, beveled edge tablet, debossed with Λ on one side and plain on the other side. They are supplied as follows: 67 NDC 72888-153-30, bottles of 30. NDC 72888-153-01, bottles of 100. NDC 72888-153-05, bottles of 500. NDC 72888-153-00, bottles of 1000.
CLONAZEPAM Tablets USP, 2 mg are white to off-white, round, flat-faced, beveled edge tablets, debossed with Λ on one side and plain on the other side. They are supplied as follows: 69 NDC 72888-154-30, bottles of 30. NDC 72888-154-01, bottles of 100. NDC 72888-154-05, bottles of 500. NDC 72888-154-00, bottles of 1000. Store at 20°C to 25°C (68°F -77°F) [See USP Controlled Room Temperature]. All trademarks are the property of their respective owners. Dispense with Medication Guide available at: www.advagenpharma.com/medguide/clonazepamtablets Manufactured by: Rubicon Research Private Limited Ambernath, Dist: Thane, 421506 India Distributed by: Advagen Pharma Ltd 666 plainsboro Road Suite 605 plainsboro, NJ 08536, US Revision: 09/22 image description
More pills like ROUND A 67